LSI USA

Gain insights from industry leaders as they discuss innovative strategies for advancing healthcare and business development, highlighting the collaboration between Mayo Clinic and W. L. Gore & Associates. For more details watch this video: https://www.lifesciencemarketresearch.com/videos/keynote-bret-snyder-ceo-of

Keynote: Mike Mahoney, CEO of Boston Scientific, and Peter Noseworthy, Chair, Cardiac Electrophysiology, Professor, Medical Director at Mayo Clinic | LSI USA ’26. Join industry leaders as they discuss innovations and strategies in cardiac care, focusing on the intersection of medical technology and clinical practice. For more details watch this video: https://www.lifesciencemarketresearch.com/videos/keynote-mike-mahoney-ceo-of

Opening Fireside Chat with Omar Ishrak and Jean Nehme | LSI USA ’26. Join industry leaders as they discuss the future of healthcare innovation, drawing on insights from leadership experiences at Medtronic and Qubit Health Capital. For more details watch this video: https://www.lifesciencemarketresearch.com/videos/opening-fireside-chat-with-omar

“If you think about hypertension, it’s a global healthcare crisis,” said Eso. “Half of this auditorium probably has it. It’s bigger than diabetes, bigger than many other diseases from a cardiovascular perspective.” Eso traced Medtronic’s entry into hypertension therapeutics back to its 2009 investment in Ardian, the pioneer behind renal denervation devices. At the time, hypertension management was still viewed almost exclusively through a pharmaceutical lens. Devices weren’t yet considered part of the solution. However, early clinical learnings revealed significant gaps that medication alone couldn’t fill — particularly in adherence. To read more about visit here: https://anyflip.com/ybicl/xonm/basic

LSI has secured discounted room blocks at our host hotel, the Waldorf Astoria Monarch Beach Resort, as well as two nearby properties. These exclusive LSI rates are limited and sell out early each year. We strongly recommend booking your room as soon as possible to ensure availability. For more information visit our website: https://www.lsiusasummit.com/2026/venue-and-travel

  To level-set the discussion, Mullings began by asking the panelists to define what “open” and “closed” mean in the context of soft tissue robotics. Greg Roche, CEO of Distalmotion, put it simply: “Choice is the difference between open and closed. When you close something down, you limit the offering in the long term.” Roche argued that open systems allow surgeons and hospitals to pick best-in-class technologies across the surgical stack, building a custom ecosystem instead of being locked into a single vendor. Scott Huennekens, former CEO of Verb Surgical and longtime digital surgery leader, offered a broader systems view. “I never even liked the term ‘robotic surgery.’ I always preferred ‘digital surgery,’” he said. “It’s not just about the robot. It’s about instruments, connectivity, data, analytics, and precision guidance, all working together.” For more information visit here:  https://anyflip.com/ybicl/nomu/basic